Alligator Bioscience
Staffan Encrantz – born in 1951, Board member since 2022 – has a Law degree (Summa Cum Laude) from Uppsala University, Sweden. Staffan Encrantz is the founder and president of Allegro Investment, Inc., a company based in Menlo Park, California, which manages a $750 million investment portfolio. He has actively led investments in and operation of a variety of companies for over 30 years and has led the growth and development of both early-stage companies and established businesses in a wide variety of fields. Additionally, Staffan has extensive experience in commercial real estate, primarily in Sweden and USA, and in the hedge fund industry as representing substantial investors in a number of hedge funds and as a former Board member of MKM Longboat Multi-Strategy Fund Ltd. as well as a Board member of Harbour Solutions Group Ltd.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Alligator Bioscience
1 followers
Alligator Bioscience utvecklar antikroppsbaserade läkemedel för behandling av cancer. Bolaget är specialiserat på utveckling av tumörriktad immunterapier.